Skip to content

Dual Mobility Total Joint Prosthesis (Touch) for Thumb Carpometacarpal Joint Osteoarthritis

Dual Mobility Total Joint Prosthesis (Touch) for Thumb Carpometacarpal Joint Osteoarthritis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05047744
Enrollment
100
Registered
2021-09-17
Start date
2019-09-15
Completion date
2023-12-31
Last updated
2022-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhizarthrosis

Keywords

CMC I Osteoarthritis, Total Joint Replacement, Hand Surgery

Brief summary

The dual mobility concept currently represents the newest generation of thumb carpometacarpal prostheses. The aim of this study was to evaluate the outcomes of TOUCH® prosthesis. From September 2019 to December 2023,a minimum of 100 prosthesis shall be implanted in patients suffering from symptomatic stage III osteoarthritis. All included patients will follow a systematic follow-up regimen (4, 8, 16 weeks, 6, and 12 months as well as 24 months postoperatively). Radiographics, ROM, VAS, DASH and Pinch grip are measured. Aim of the study is to compare clinical outcome of dual mobility prosthesis with common results of CMC I Prosthesis in literature.

Detailed description

The dual mobility concept currently represents the newest generation of thumb carpometacarpal prostheses. The aim of this study was to evaluate the outcomes of TOUCH® prosthesis. From September 2019 to December 2023,a minimum of 100 prosthesis shall be implanted in patients suffering from symptomatic stage III osteoarthritis. All included patients will follow a systematic follow-up regimen (4, 8, 16 weeks, 6, and 12 months as well as 24 months postoperatively). Radiographics, ROM, VAS, DASH and Pinch grip are measured. Aim of the study is to compare clinical outcome of dual mobility prosthesis with common results of CMC I Prosthesis in literature. The Study is designed to give clinical results after one year, 2 years and also long time results in the future.

Interventions

DEVICETouch Dual Mobility CMC I Prosthesis

Surgery

Sponsors

Kepler University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective non randomized Clinical Trial

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* CMC I Osteoarthritis /Stage III)

Exclusion criteria

* CMC I (osteoarthritis / Other Stage than III) * Anticoagulation

Design outcomes

Primary

MeasureTime frameDescription
DASH Score (Disability of Arm Shoulder and Hand Score)24 monthsDASH Score is taken before Surgery and after 6, 12 and 24 months DASH (Disabilty of Arm Shoulder and Hand) Score reaches from 0-100, whereas 0 reprensents best score while 100 represents worst

Secondary

MeasureTime frameDescription
Subjective Pain24 monthspatients report about subjective Pain level in average at 6, 12 and 24 months in a VAS (Visual Analog Pain Scale) scale (0-10), whereas 0 is best and 10 worst

Countries

Austria

Contacts

Primary ContactStefan M Froschauer, MD
stefan.froschauer@kepleruniklinikum.at004373278061020
Backup ContactOskar Kwasny, Prof
oskar.kwasny@kepleruniklinikum.at004373278061010

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026